CORRESP 1 filename1.htm ctdh20201204_corresp.htm

 

Cyclo Therapeutics, Inc.

6714 NW 16th Street, Suite B

Gainesville, FL 32653

 

December 4, 2020

 

VIA EDGAR

 

U.S. Securities and Exchange Commission

100 F Street, N.E.

Mail Stop 4628

Washington, DC 20549

Division of Corporation Finance, Office of Life Sciences

Attn: Chris Edwards

 

 

Re:

Cyclo Therapeutics, Inc.

 

 

Registration Statement on Form S-1

 

 

Filed September 29, 2020, as amended

 

 

File No. 333-249136

 

 

Dear Mr. Edwards:

 

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Cyclo Therapeutics, Inc. hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 4:30 p.m. EST on Monday, December 7, 2020, or as soon as thereafter practicable.

   
 

Very truly yours,

   
 

/s/ N. Scott Fine

 

N. Scott Fine

 

Chief Executive Officer

 

 

cc:

Fox Rothschild LLP

Ellenoff Grossman & Schole LLP